SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001193125-22-140444
Filing Date
2022-05-04
Accepted
2022-05-04 16:03:45
Documents
2

Document Format Files

Seq Description Document Type Size
1 POS AM d312801dposam.htm POS AM 69005
2 EX-23.2 d312801dex232.htm EX-23.2 1788
  Complete submission text file 0001193125-22-140444.txt   71827
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Filer) CIK: 0001609809 (see all company filings)

IRS No.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-244401 | Film No.: 22891451
SIC: 2834 Pharmaceutical Preparations